Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
NCT00393471 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 615
Last updated 2023-12-13
Summary
To compare the therapeutic and radiographic effects and safety between etanercept, methotrexate, and the etanercept/methotrexate combination in patients with rheumatoid arthritis.
Conditions
- Active Rheumatoid Arthritis
Interventions
- DRUG
-
Etanercept
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
-
Trial Manager · For Australia, [email protected]
-
Trial Manager · For Austria, [email protected]
-
Trial Manager · For Belgium, [email protected]
-
Trial Manager · For Czech Republic, [email protected]
-
Trial Manager · For Denmark, Finland, Norway, and Sweden, [email protected]
-
Trial Manager · For France, [email protected]
-
Trial Manager · For Germany, [email protected]
-
Trial Manager · For Greece, [email protected]
-
Trial Manager · For Italy, [email protected]
-
Trial Manager · For Netherlands, [email protected]
-
Trial Manager · For Poland, [email protected]
-
Trial Manager · For Romania, [email protected]
-
Trial Manager · For Spain, [email protected]
-
Trial Manager · For UK/Great Britian, [email protected]
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Completion
- 2001-10-31
Countries
- Australia
- Austria
- Belgium
- Czechia
- Denmark
- Finland
- France
- Germany
- Greece
- Israel
- Italy
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Spain
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
NCT01578850 ·Status: COMPLETED ·Phase: PHASE4
-
Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
NCT02376790 ·Status: COMPLETED ·Phase: PHASE3
-
A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)
NCT00520572 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study
NCT00522184 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
NCT00244556 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis
NCT00783536 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
NCT00252668 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis
NCT00445770 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
NCT00459706 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis
NCT03332719 ·Status: COMPLETED ·Phase: PHASE3
-
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
NCT00713544 ·Status: COMPLETED ·Phase: PHASE2
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
NCT00484237 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis
NCT00443950 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy
NCT00848354 ·Status: COMPLETED ·Phase: PHASE4
-
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
NCT00405275 ·Status: COMPLETED ·Phase: NA
-
Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab
NCT01927757 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
NCT01783015 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan
NCT00688103 ·Status: COMPLETED ·Phase: PHASE4
-
This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.
NCT04267614 ·Status: COMPLETED
-
Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)
NCT01303874 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region
NCT00422227 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Trial With Enbrel
NCT00488475 ·Status: COMPLETED
-
Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
NCT03781375 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT00962741 ·Status: COMPLETED ·Phase: PHASE3